Loading stock data…
Centene Corporation (CNC)
$67.04-0.98 (-1.44%)
Pre-Market$66.75-0.29 (-0.43%)· Last close Sep 4
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Centene Corporation in the Healthcare sector is trading at $67.04 with a market capitalization of $33.1B. Wall Street consensus targets $71.67 (18 analysts), implying a +6.9% move over the next 12 months. The stock is currently near its 52-week high of $69.36, remaining 33.2% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +6.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $53.58B↑ | $49.94B↑ | $49.73B | $49.69B↑ | $48.74B |
| Gross Profit | $4.60B↓ | $5.56B↑ | $2.47B↓ | $3.25B↑ | $2.95B |
| Operating Income | $1.20B↓ | $1.86B↑ | -$1.23B↓ | -$211.00M↑ | -$403.00M |
| Net Income | $1.09B↓ | $1.54B↑ | -$1.10B↑ | -$6.63B↓ | -$253.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$33.13B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.10
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-22.60%
Volume
Today's trading volume
2.78M
Recent News
Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.
4 Stocks Trading Near 52-Week High With Room to Rise Further
Investors target stocks that have been on a bullish run. Stocks like PRAA, CNC, BILL and PARR are seeing price strength, and the momentum is likely to continue.
UnitedHealth Stock Recovered Before Its Margins Did
UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.
How Can Healthcare Inflation Fuel Growth for MRSH, UNH & CNC?
Rising employer healthcare costs could boost Marsh's consulting demand and create growth avenues for UnitedHealth and Centene through cost-control solutions.
Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
Here is how Adicet Bio, Inc. (ACET) and Centene (CNC) have performed compared to their sector so far this year.